On the public citation graph

Autologous Adoptive Cellular Immunotherapy as an Effective Prophylactic Concurrent Treatment in Reducing the Severity and Mortality of COVID-19 Infection in Cancer Patients

https://doi.org/10.2139/ssrn.4632955
0 signed · 15 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.ijid.2020.12.051openalex-extracted
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count
inferredcites →https://doi.org/10.1016/j.immuni.2016.05.006openalex-extracted
Airway Memory CD4 + T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
inferredcites →https://doi.org/10.1016/j.pharmthera.2023.108399openalex-extracted
The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases
inferredcites →https://doi.org/10.1016/j.vaccine.2016.02.063openalex-extracted
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
inferredcites →https://doi.org/10.1038/s41586-020-2550-zopenalex-extracted
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
inferredcites →https://doi.org/10.1038/s41586-020-2918-0openalex-extracted
Age-specific mortality and immunity patterns of SARS-CoV-2
inferredcites →https://doi.org/10.1080/02656736.2019.1647350openalex-extracted
Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors
inferredcites →https://doi.org/10.1080/14712598.2020.1728250openalex-extracted
DC-CIK as a widely applicable cancer immunotherapy
inferredcites →https://doi.org/10.1111/ijcp.13858openalex-extracted
The impact of charlson comorbidity index on mortality from SARS‐CoV‐2 virus infection and A novel COVID‐19 mortality index: CoLACD
inferredcites →https://doi.org/10.1111/imm.13262openalex-extracted
T‐cell responses and therapies against SARS‐CoV‐2 infection
inferredcites →https://doi.org/10.1128/jvi.01505-14openalex-extracted
Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection
inferredcites →https://doi.org/10.1136/jitc-2021-004157openalex-extracted
Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study
inferredcites →https://doi.org/10.1158/2159-8290.cd-21-1441openalex-extracted
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
inferredcites →https://doi.org/10.21203/rs.3.rs-79476/v1openalex-extracted
Serial Assessment of Circulating T lymphocyte Phenotype and Receptor Repertoire During Treatment of Non-Muscle Invasive Bladder Cancer with Adoptive T Cell Immunotherapy
inferredcites →https://doi.org/10.3390/cancers14225630openalex-extracted
Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.